AT13387 in Cancer Biology: Unraveling Hsp90 Inhibition and R
2026-07-06
Explore the advanced mechanisms of the Hsp90 inhibitor AT13387 in cancer biology research. This article uniquely bridges high-affinity Hsp90 inhibition with emerging insights into regulated cell death, providing novel assay perspectives for apoptosis and cell cycle arrest studies.
11β-HSD1 Inhibition Reduces Liver Fibrosis via Notch Suppres
2026-07-06
This study demonstrates that a novel 11β-HSD1 inhibitor significantly attenuates liver fibrosis in a thioacetamide-induced mouse model by suppressing the Notch signaling pathway and enhancing NK cell-mediated immune responses. These mechanistic insights highlight new therapeutic avenues for metabolic dysfunction-associated steatotic liver disease (MASLD) and inform the design of next-generation liver fibrosis models.
Optimizing Storage for LNP-Formulated Self-Replicating RNA V
2026-07-05
This study systematically evaluates how storage conditions impact the stability and in vivo potency of lipid nanoparticle (LNP)-formulated self-replicating RNA vaccines. The findings provide evidence-based protocols for maintaining vaccine efficacy, offering important guidance for both vaccine development and preclinical research workflows.
Magneto-Piezoelectric Scaffolds Activate JAK2-STAT3 in Bone
2026-07-04
The referenced ACS Nano study introduces a multifunctional scaffold integrating magneto-piezoelectric nanoparticles to both disrupt biofilms and activate oxidative phosphorylation in Icam1+ macrophages. This dual-action platform leverages JAK2-STAT3 signaling to enhance bone regeneration in infectious defect models, demonstrating a significant advance for orthopedic tissue engineering.
CDK4/6 and BET Inhibition Synergizes to Reverse EMT in PDAC
2026-07-03
Gu et al. (2025) demonstrate that combined CDK4/6 and BET inhibition in pancreatic ductal adenocarcinoma synergistically suppresses tumor growth and reverses epithelial-to-mesenchymal transition (EMT) by modulating GSK3β-mediated Wnt/β-catenin and TGF-β/Smad signaling. This mechanistic insight addresses a critical paradox in single-agent therapies and informs the refinement of targeted preclinical combination strategies.
Prevotella copri Drives Breast Cancer via IPyA Depletion and
2026-07-03
This study reveals that enrichment of Prevotella copri in the gut microbiota of breast cancer patients accelerates tumor progression by depleting host indole-3-pyruvic acid (IPyA), a physiologic anti-cancer metabolite. Mechanistic experiments show this depletion promotes UHRF1-mediated inactivation of the AMPK pathway, highlighting a novel microbiome-metabolite axis in breast cancer biology.
Acetylcholine Chloride: Enabling Translational Breakthroughs
2026-07-02
Discover how Acetylcholine Chloride advances gut-brain cholinergic signaling research and translational neuroscience. This article explores innovative assay strategies, mechanistic insights, and future directions, offering a deeper perspective on the acetylcholine neurotransmitter's pivotal role.
Resazurin Sodium Salt: Fluorogenic Indicator for Cell Viabil
2026-07-02
Resazurin sodium salt is a highly sensitive fluorogenic oxidation-reduction indicator used to quantify cell viability and cytotoxicity in biological assays. It enables rapid, reproducible assessment of cell proliferation, particularly in high-throughput screening and cancer research. Proper optimization of concentration and incubation parameters is critical to avoid assay artifacts and ensure accurate results.
MCC950 Sodium in Inflammatory Disease Research: Protocols &
2026-07-01
MCC950 sodium (CRID3 sodium salt) stands at the forefront of NLRP3 inflammasome inhibition, enabling precise modulation of inflammatory and autoimmune disease models. This guide details experimental workflows, troubleshooting, and practical tips for leveraging MCC950 sodium in translational research.
0.4% Trypan Blue Solution: Practical Guide for Cell Viabilit
2026-07-01
0.4% Trypan Blue Solution provides a straightforward, dye-based method for distinguishing viable from non-viable cells in cell counting, viability, and cytotoxicity workflows. This reagent is designed for research settings and should not be used for diagnostic or clinical applications. Its effective use depends on adherence to best practices in preparation, handling, and interpretation.
Affinity-Purified Goat Anti-Rabbit IgG (H+L), HRP: Mechanism
2026-06-30
The HRP Goat Anti-Rabbit IgG (H+L) Antibody from APExBIO is an affinity-purified, horseradish peroxidase-conjugated secondary antibody enabling robust signal amplification in immunoassays. Its specificity for both heavy and light chains of rabbit IgG ensures low background and high sensitivity. This dossier details its validated mechanisms, application boundaries, and integration parameters.
SIS3 (Smad3 inhibitor): Practical Solutions for TGF-β Resear
2026-06-30
This scenario-driven article demonstrates how SIS3 (Smad3 inhibitor, SKU B6096) streamlines cell-based TGF-β signaling research, offering reproducible, literature-backed solutions for experimental challenges. By integrating recent data and workflow insights, researchers can enhance assay reliability and interpretability using SIS3 from APExBIO.
Hepatic sEH Drives Osteoclastogenesis via Nrf2 Suppression i
2026-06-29
A recent study reveals that hepatic soluble epoxide hydrolase (sEH) exacerbates osteoclast differentiation and bone loss by suppressing the Nrf2 antioxidant pathway. These findings establish a new liver-bone signaling axis in osteoporosis and suggest that sEH inhibition could be a promising strategy for modulating bone metabolism and redox balance.
Sulfachloropyridazine for Reliable Antimicrobial Assays: Lab
2026-06-29
Sulfachloropyridazine (SKU BA1082) offers biomedical researchers a robust, research-grade sulfonamide antibacterial agent for enzyme inhibition assays, antimicrobial susceptibility testing, and in vivo infection models. This article presents scenario-driven guidance, evidence-backed protocol optimization, and practical benchmarks for laboratory scientists seeking reproducible, interpretable data with Sulfachloropyridazine.
Phosphatase Inhibitor Cocktail (2 Tubes, 100X): Technical Gu
2026-06-28
The Phosphatase Inhibitor Cocktail (2 Tubes, 100X) addresses the persistent challenge of preserving protein phosphorylation during sample preparation by inhibiting both serine/threonine and tyrosine phosphatases. It is best suited for workflows requiring accurate analysis of phosphorylation states, such as immunoblotting and kinase assays. It should not be used for diagnostic or clinical applications, nor when phosphatase activity measurement is required.
508 records 16/34 page Previous Next First page 上5页 1617181920 下5页 Last page